TY - JOUR
AU - Voss, Erica A.
AU - Shoaibi, Azza
AU - Yin Hui Lai, Lana
AU - Blacketer, Clair
AU - Alshammari, Thamir M.
AU - Makadia, Rupa
AU - Haynes, Kevin
AU - Sena, Anthony G.
AU - Rao, Gowtham A.
AU - van Sandijk, Sebastiaan
AU - Fraboulet, Clement
AU - Boyer, Laurent
AU - Le Carrour, Tanguy
AU - Horban, Scott
AU - Morales, Daniel R.
AU - Martínez Roldán, Jordi
AU - Ramírez-Anguita, Juan Manuel
AU - Mayer, Miguel Angel
AU - de Wilde, Marcel
AU - John, Luis H.
AU - Duarte-Salles, Talita
AU - Roel, Elena
AU - Pistillo, Andrea
AU - Kolde, Raivo
AU - Maljković, Filip
AU - Denaxas, Spiros
AU - Papez, Vaclav
AU - Kahn, Michael G.
AU - Natarajan, Karthik
AU - Reich, Christian G.
AU - Secora, Alex
AU - Minty, Evan P.
AU - Shah, Nigam H.
AU - Posada, Jose D.
AU - Garcia Morales, Maria Teresa
AU - Bosca, Diego
AU - Cadenas Juanino, Honorio
AU - Diaz Holgado, Antonio
AU - Pedrera Jiménez, Miguel
AU - Serrano Balazote, Pablo
AU - García Barrio, Noelia
AU - Şen, Selçuk
AU - Üresin, Ali Yağız
AU - Erdogan, Baris
AU - Belmans, Luc
AU - Byttebier, Geert
AU - Malbrain, Manu L.N.G.
AU - Dedman, Daniel J.
AU - Cuccu, Zara
AU - Vashisht, Rohit
PY - 2023
DA - April
TI - Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study
JO - EClinicalMedicine
VL - 58
DO - https://doi.org/10.1016/j.eclinm.2023.101932
AB - Background: Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with COVID-19. Our aim was to characterise the incidence rates of AESIs following SARS-CoV-2 infection in patients and compare these to historical rates in the general population.
PB - Elsevier
UR - https://discovery.dundee.ac.uk/en/publications/4d978a22-777b-444f-80a6-60fd716d2a08
KW - Coronavirus (COVID-19)
ER